About Me
His creative approaches have led to the discovery of two virulence factors (Vpu and Vpr) encoded by HIV and his pioneering studies on the interactions between HIV and antiviral effectors of the host innate immune response have fostered a transforming understanding of HIV persistence and opened new avenues for the development of HIV curative strategies. Dr. Cohen is currently leading the Canadian HIV Cure Enterprise, a large research endeavor that is part of Canada's contribution to the global efforts towards an HIV cure.